ABSTRACT
Since 2020, the world has been impacted badly by the pandemic situation that arose due to the coronavirus. Artificial intelligence plays a crucial role in the healthcare system, specifically identifying symptoms of disease with the help of various machine learning algorithms during the diagnosis stage. The identified symptoms in various diagnostic tests are used to predict the clinical outcome of early detection of diseases, which results in human life saving. Machine learning algorithms have been successfully used in automated interpretation. With the advanced technology of cybersecurity aspects, we can emphasize data protection for better results. Artificial intelligence can enhance the security of medical science data. Furthermore, they improvise cybersecurity techniques with machine learning technologies. © 2023, The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
ABSTRACT
Since 2020, the world has been impacted badly by the pandemic situation that arose due to the coronavirus. Artificial intelligence plays a crucial role in the healthcare system, specifically identifying symptoms of disease with the help of various machine learning algorithms during the diagnosis stage. The identified symptoms in various diagnostic tests are used to predict the clinical outcome of early detection of diseases, which results in human life saving. Machine learning algorithms have been successfully used in automated interpretation. With the advanced technology of cybersecurity aspects, we can emphasize data protection for better results. Artificial intelligence can enhance the security of medical science data. Furthermore, they improvise cybersecurity techniques with machine learning technologies. © 2023, The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
ABSTRACT
Nowadays, in this COVID era, work from home is quietly more preferred than work from the office. Due to this, the need for a firewall has been increased day by day. Every organization uses the firewall to secure their network and create VPN servers to allow their employees to work from home. Due to this, the security of the firewall plays a crucial role. In this paper, we have compared the two most popular open-source firewalls named pfSense and OPNSense. We have examined the security they provide by default without any other attachment. To do this, we performed four different attacks on the firewalls and compared the results. As a result, we have observed that both provide the same security still pfSense has a slight edge when an attacker tries to perform a Brute force attack over OPNSense. © 2022 IEEE.
ABSTRACT
Introduction: Favipiravir has shown promising results for COVID-19 globally. Though many Indian patients have received favipiravir, there is a lack of realworld data for its clinical use by the practicing physicians. Hence, a qualitative survey was conducted to understand real-world use of favipiravir in management of COVID-19. Methods: A cross-sectional, web-based, qualitative survey was conducted between September 2020 to October 2020, among Indian physicians from various specialties involved in COVID-19 care and using favipiravir in their practice. Physicians were provided survey link having a structured questionnaire with 32 questions. They were enquired on- 1) demographics,practice information, 2) place of favipiravir in clinical practice, 3) treatment protocol for mild to moderate COVID-19, 4) dosage and duration of favipiravir, 5) effectiveness of favipiravir, 6) tolerability of favipiravir 7) global efficacy and safety assessment of favipiravir. Results: A total of 500 physicians were contacted, of which 50 physicians completed the questionnaire. 25(50.0%) were from south zone followed by 12(24.0%) from west. . Majority physicians (47, 97.9%) stated that favipiravir was used for COVID-19 in outpatient setting. Favipiravir was considered as the current drug of choice for ' mild COVID-19 with fever(86.6%). All physicians agreed that favipiravir was being used as per the recommended dose.. A total of 75% & 62.5% physicians agreed to observed clinical improvement by around 3-5 days & 5-7 days in symptomatic mild & moderate COVID-19 respectively. Conclusion: Majority of the physicians considered favipiravir to be safe and effective in treatment of mild to moderate COVID-19. © 2021 Journal of Association of Physicians of India. All rights reserved.